Septerna (SEPN) Cash from Financing Activities (2024 - 2026)

Septerna (SEPN) recorded quarterly Cash from Financing Activities of $333000.0 in Q1 2026, down 67.38% quarter-over-quarter from $1.0 million in Q4 2025, and up 404.55% on a YoY basis from $66000.0 in Q1 2025.

Septerna (SEPN) Cash from Financing Activities (2024 - 2026) Analysis & Trends

Septerna's Cash from Financing Activities history runs 3 years deep, the most recent figure standing at $333000.0 for Q1 2026.

  • In Q1 2026, Cash from Financing Activities rose 404.55% year-over-year to $333000.0; the TTM figure through Mar 2026 stood at $2.0 million (down 99.35% YoY), while the FY2025 annual figure was $1.7 million, down 99.55% from the prior year.
  • Cash from Financing Activities was $333000.0 for Q1 2026 at Septerna, down from $1.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $304.2 million in Q4 2024 to a low of -$1.3 million in Q3 2024.
  • Historically, Cash from Financing Activities has averaged $43.6 million across 3 years, with a median of $333000.0 in 2026.
  • The sharpest annual moves came in 2025 and 2026: Cash from Financing Activities sank 99.66% in 2025, then surged 404.55% in 2026.
  • A 3-year view of Cash from Financing Activities shows it stood at $304.2 million in 2024, then tumbled by 99.66% to $1.0 million in 2025, then tumbled by 67.38% to $333000.0 in 2026.
  • The last three Cash from Financing Activities figures came in at $333000.0 (Q1 2026), $1.0 million (Q4 2025), and $263000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Septerna 1.62 Bn 1.62 Bn - 333,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 333,000.00
Mar 31, 2026 333,000.00
Dec 31, 2025 1.02 Mn
Dec 31, 2025 1.02 Mn
Sep 30, 2025 263,000.00
Sep 30, 2025 263,000.00
Jun 30, 2025 339,000.00
Jun 30, 2025 339,000.00
Mar 31, 2025 66,000.00
Mar 31, 2025 66,000.00
Dec 31, 2024 304.15 Mn
Dec 31, 2024 304.15 Mn
Sep 30, 2024 -1.32 Mn
Sep 30, 2024 -1.32 Mn